Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Blow offs are usually associated which much higher relative volume...like, many times the norm. The volume over the past week(s) is solid, but in order to have a blow off day, you would need volume several times the average.
You weren't saying the same thing when ARIA was at 43.00, were you?
This type of talk makes me want to sell more and more.
Good read.
Never saw that before, thanks.
THIS run, may very well have to do with a few things:
1. July: Lung Cancer World Conference & Potential NDA for Ridaforolimus
(but more likely.....)
2. Hedge funds who have to report to their partners their positions: if they show they have a huge short position in a stock that has had a great quarter, they're going to look like morons (especially if their long performance sucked just as bad - it was a tough quarter for most asset managers). They'd want to cover that position to spare themselves the embarrassment and questions. Further... if you're long, you are potentially window-dressing your portfolio to show you had winners such as Ariad.
Personally, I want to see a blow-off rally on big big volume before I take a lot, if not all, off the table. It has been a good run..I am not quite sure it's over yet.
I am up nearly 1,000% on some positions I took a long time ago. That's a lot, and it's not something I am going to be confortable with myself if those gains evaporate because I got greedy (a common mistake).
I'm hoping it gets a little parabolic here so I can sell my position.
I agree with you.
I'm looking forward to the day Avastin is second-line everything because that will mean there are a lot more effective drugs out there with much less side-effects.
(actually, I should say, 'looking forward to the day Avastin is replaced in all indications')
Do you think Avastin is a good drug?
I know it makes billions....but, in terms of benefits.
Some idiot on Yahoo said they were going to buy CRIS..LOL.
So, of course, I just took a two minute look at the company. and haven't looked at it again.
They might be a decent company, I just do not know. Haven't bothered looking at them anymore,.
Speaking of endometrial results, WTF is going on with the processing of those trials and further development of the drug in that indication?
Merck sucks, plain and simple. I really hope The Harv tells Merck to shove it up their *** if they come begging for a hand in Ponatinib.
LOL - the only reason I took a look at it is because of a rumor some moron on CRIS, Yahoo! started.
(((YAWN)))
ACTC is a joke. How many shares outstanding in that blackhole now?
Good. As long as it stays alive for 6 more months we will all be very fine here.
After that, I agree.
No, I do not know the exact terms.
I hope Berger did a good deal with them...considering BPX101 probably isn't effective (or as effective) without AP1903. But, I don't know that for sure.
Hopefully, Berger bringing up Bellicum means bigger things in the near future for Bellicum...I would like it (as a shareholder of Ariad) if they IPO'd. Be good for all of us...
I would assume its hedging. But I don't know. Or could be rolling over a contract.
As I've always said, it's really difficult to interpret these trades.
I'm looking at the 15,790 contracts (Nov5), 5,750 contracts (Nov8)..
Bellicum should IPO.
I don't know what they look like under the hood, but, now is just about the best time in many years to IPO; considering the press and relevance of these new types of novel therapies.
Some monster volume in the PUTS today
Yeah, the fact that Provenge/Dendreon has a market-cap in the several billions and doesn't shrink tumors says a lot about a possible vaccine that can actually generate PR and CR.
LOL, I'd like to move to Portland at some point.
Lot's of snow in the winter in the mountains, and near the ocean. Nice.
As "toppy" as it might look, I have yet to see a 'blow-off' type of volume move...
LOL, yes!
No, it was something else (which is now out of business).
It was brutal. This guy must have devoted most of his work week to crafting these letters.
It looks like they sold the 5,000 contracts X 2 this morning.
The recent 2,000 contracts traded look like buys.
But, it's tough to say.
I would much prefer I wake up tomorrow and see LLY offering $25/share for the whole company..
:)
If they don't like it, get other bidders.
Let me guess. You have a position in another biotech company that has operations in China and derives a substantial portion of its revenues from China so you are now "bashing" this promising young company?? ;)
LOL
Honestly, it doesn't matter if it's biotech, solar, consumer, 3D technology, whatever. Any time a small-cap company begins to speak about what it "has going on with China" there's a 90% chance it's probably a scam.
Personally, I would rather have it go straight to $15 than having a pullback.
Pullbacks = DOWN.
Dew, you are just bashing FCSC because you have a position in Allergan.
LMAO
Pharmacokinetics of Ridaforolimus in Chinese Participants (MK-8669-059)
http://clinicaltrials.gov/ct2/show/NCT01380184?term=ridaforolimus&rank=18
berger never once said there was a fourth compound. he only made inference there would be others coming....and why wouldnt he? that would be like him saying hes satisfied with what they have.
los of dumb speculation about a phantom fourth compound in development lead to all of this talk...
People seem to forget its not that easy to just pump out possible best in class candidates.
WTF. 2 possible compounds, 534 and 113 could be best in class. Obviously, 113 holds that possible promise. I highly doubt they had a fourth compound which failed in preclinical so they started pumping 1903.
534 and 113 as highly targeted agents is good enough for me.
Sell it at 30.00....please.
Yes I would be referring to him selling any of his personal stash especially in light of him continuously mentioning he hadn't sold a single share.
i dont think they had a fourth cmpound that failed. how many months was it that they announced 113 AFTER ponatinib formally entered the clinic? i dont see why everyone thinks this company has the financial resources to keep pumping out drug after drug.
i do agree.....the stock talk from berger is slightly concerning...or hes dead serious....if he starts selling shares after all his stock pumping.....then i will be very concerned.
FWIW
http://www.cnbc.com/id/43526549
ETFs. HFTs. All bogus phantom trading.
The sad thing is, some people fall in love with the sh*t they own, and actually start believe their own B.S. Heck, I've been there before...and early on, learned from those painful mistakes. I've also had my share of biotech implosions. Way back when, I might have held on to them after they imploded, hoping for the best, because I "believed".... now, after hard lessons, dump and never look back. I actually know traders who have sticky notes on their desk abiding by that lesson...they read "DO NOT EVER BUY "XXXX" just in case they forgot about getting phucked the first time around.
You mention SOMX in a post. That's a miserable chart. You are right on, there.